Beximco Pharma
An editor has nominated this article for deletion. You are welcome to participate in the deletion discussion, which will decide whether or not to retain it. |
 | This article contains content that is written like an advertisement. (November 2006) |
Beximco Pharmaceuticals Ltd, also known as Beximco Pharma is a major pharmaceutical company based in Bangladesh. It is part of the Beximco Group of Companies.
| File:BeximcoPharma.jpg | |
| Company type | Ltd |
|---|---|
| Industry | Pharmaceutical |
| Founded | 1980 |
| Headquarters | Tongi, Dhaka, Bangladesh |
Key people | Nazmul Hassan CEO |
| Website | http://www.beximco-pharma.com/ |
Corporate History
Beximco Pharma started operations in 1980, manufacturing products under the licenses of Bayer AG of Germany and Upjohn Inc. of USA. BP has now grown to become one of Bangladesh's leading pharmaceutical companies, supplying more than 10% of country's total medicine need. Today Beximco Pharma manufactures and markets its own branded generics for several diseases including AIDS, cancer, asthma, hypertension, and diabetes for both national and international markets.
Factories
Beximco Pharma manufacturing facilities are spread across a 20-acre site located in Dhaka, Bangladesh. The facilities comprise of a number of purpose-built plants, including a new Oral Solid Dosage (OSD) plant. The site includes manufacturing facilities as well as a research laboratory and a number of warehouses. The plant and machinery of the facilities were designed, produced and installed by partners from Germany, Switzerland, Sweden, Italy and the United Kingdom, amongst others.
Business Information
The company's annual production exceeds $50 million. It employs over 1900.
Philippines
On August, 2007, Beximco exported its medicines to the Philippines, the 5th country of the 10-member Association of South East Asian Nations (ASEAN) to import Beximco's drugs. Beximco Chief Executive Nazmul Hassan said that exports to the Philippines include metered dose inhalers, and nasal sprays, and other medications. The Philippine pharmaceutical market ($1.3 billion in 2007), is highly dependent on imported medicines.[1]
External links